• Title/Summary/Keyword: Pharmaceutical Industry of Korea

Search Result 258, Processing Time 0.026 seconds

Institutional Change and Organizational Change: A Multicase Study on the Organizational Adaptation to the Introduction of Pharmacoeconomics (제도 환경 변화와 조직 변화 : 경제성 평가의 도입과 다국적 제약기업의 조직 적응에 대한 다중사례연구)

  • Lee, Hye-Jae;You, Myoung-Soon;Lee, Tae-Jin
    • Health Policy and Management
    • /
    • v.21 no.3
    • /
    • pp.425-456
    • /
    • 2011
  • Background: Organizations in the pharmaceutical industry are highly dependent on the institutional environment. The introduction of pharmacoeconomics to the decision-making on the price and reimbursement decisions became strong constraints to pharmaceutical companies in Korea. As little is known about the issue on organization-environment interaction in the healthcare field, this study aimed to figure out how pharmaceutical companies adapted to the environmental changes. Methods: A multicase study method was used, selecting eight cases among multi-national pharmaceutical companies in South Korea. In-depth interviews were conducted with the managers of these organizations, and secondary data were reviewed to complement the interviews. Results: Pharmaceutical companies viewed the new policies as a big threat and sought for actions against them. One of the most distinguishing organizational changes was to construct a Market Access department. Other strategies managing the environment such as co-optation, forecasting, and bargaining were also implemented. These changes were consistent with the predictions of Resource Dependency Theory and Institutional Theory. Conclusions: The interactions between pharmaceutical companies and institutional environments in healthcare were first explored. This study presents a new perspective on how organizations change and the motives for the changes. The findings of this case study will form the basis of further empirical studies.

A Study on the Selection of Strategic Industry in Gyeonggi Province (경기도 지역 전략산업 선정에 관한 시론적 연구)

  • Kim, Shin-Pyo
    • Journal of Industrial Convergence
    • /
    • v.12 no.2
    • /
    • pp.16-23
    • /
    • 2014
  • The aim of this study is to find the strategic industries that fulfills the on-site demands of the Gyeonggi province region related to the advancement and development of the local industries. As the results of the analysis, the 4 major strategic industries in the Gyeonggi province region were determined to be (1) electronic component, computer, visual, acoustic and telecommunication equipment manufacturing, (2) pulp, paper and paper product manufacturing, (3) medical substances and pharmaceutical product manufacturing, and (4) rubber and plastic product manufacturing. The industry of concordance between the 4 major strategic industry of the Gyeonggi province determined in this Study and the 13 future growth engine industry of Korea was the area of intelligent semiconductor. Accordingly, it was analyzed that there is a need to strategically cultivate the electrical and electronic telecommunication device industry, which is ranked the $1^{st}$among the strategic industries of Gyeonggi province by generating synergic effects with the policy of the government for nurturing of intelligent semiconductor industry.

  • PDF

Antioxidant and Hyaluronidase Inhibition Activities of Prunus persica Batsch var. davidiana Maximowicz

  • Cha, Bae-Cheon;Lee, Eun-Hee
    • Proceedings of the PSK Conference
    • /
    • 2003.10b
    • /
    • pp.200.3-200.3
    • /
    • 2003
  • Reactive oxygen species(ROS) are produced at a high rate continuously as a by-product of aerobic metabolism. Several lines of evidence provided that ROS appears to cause to develop aging and various diseases. High level of hyaluronic acid with decreased molecular weight has been detected in patients with inflammatory diseases including rheumatoid arthritis. Hyaluronidase is an endohexosaminidase that initiates the degradation of hyaluronic acid with high molecular weight. Prunus persica Batsch var. davidiana Maximowicz has been known as a korean folk medicine for treatment of neuritis and rheumatism. (omitted)

  • PDF

A Study on the Factors Influencing the Satisfaction of Certification and Support Policy of Innovative Pharmaceutical Companies : Focusing on the policy formation process variables (혁신형 제약기업 인증·지원 정책만족도에 대한 영향요인 연구 : 정책형성과정 변인을 중심으로)

  • Kim, Daejin;Oh, Kihwan;Ha, Dongmun
    • Journal of the Korea Academia-Industrial cooperation Society
    • /
    • v.19 no.8
    • /
    • pp.360-369
    • /
    • 2018
  • Innovative pharmaceutical company certification support policies have been implemented since 2012. This study was conducted to identify the perceptions of stakeholders and related experts on the formation process and policy satisfaction of this policy, and to identify factors that explain policy satisfaction. The survey was conducted by e-mail and facsimile of the pharmaceutical companies, universities, and government - affiliated research institutes. The effective response rate was 38.4% (61/159). As a result of the cross-sectional survey, the perception of policy necessity was the most positive among the policy formation process, and all the other stages and perception of policy satisfaction were at the medium level. As a result of examining the influential factors related to the variables of the respondents' personal variables and the policy formation process, it is confirmed that the factors that have the greatest influence on the policy satisfaction are the perception of the performance of the certified company. Also, perceptions of appropriateness and follow - up ability were similar in magnitude of impact on policy satisfaction. This study can be used as a basic data to systematically and effectively improve the certification and support policies of innovative pharmaceutical companies based on the consumer's perception. However, due to limitations such as being carried out at the beginning of policy implementation, verification and supplementation are necessary through further research.

Long-term measurement of physiological cardiovascular parameters using telemetry system in dosgs.

  • Kim, Eun-Joo;Seo, Joung-Wook;Choi, Gyu-Kap;Park, Eun-Kyung;Kim, Ki-Suk;Shin, Won-Ho;Han, Sang-Seop
    • Proceedings of the PSK Conference
    • /
    • 2003.10b
    • /
    • pp.87.1-87.1
    • /
    • 2003
  • With the issuance of the ICH “Guidance for industry S7A Safety Pharmacology Studies For Human Pharmaceuticals” in July 2001 came the preference for the use of unanesthetized animals when evaluation the safety profile of new pharmaceutical agents. Telemetry provides a means of obtaining measurements of physiological functions in conscious animals without the problems associated with classical cardiovascular measuring methods. The Korea Institute of Toxicology (KIT) established the telemetric measurement of cardiovascular parameters, such as Blood pressure, Heart rate, ECG (PR, RR, QRS, QT and QTcB interval) under GLP conditions. (omitted)

  • PDF

Study on Decomposition of Several Pesticides by Gamma-Irradiation (감마선 조사에 의한 농약 성분의 분해 연구)

  • Lee, Joo-Sang;Jung, Su-Yeon;Oh, Seung-Yeol;Jang, Beom-Su;Park, Sang Hyun
    • Journal of Radiation Industry
    • /
    • v.6 no.3
    • /
    • pp.205-209
    • /
    • 2012
  • The decomposition of 50 pesticides present in an aqueous solution using ${\gamma}-irradiation$ from a $^{60}Co$ gamma-ray source was investigated using laboratory-scale experiment. The rates of decomposition were determined using a gas chromatography-electron capture detector (GC-ECD), high-performance liquid chromatography-photo diode array detector (HPLC-PDA), and HPLC-fluorescence detector (FLD). When the initial concentration of pesticides was 10 ppm, and the radiation dose was 2, 5, 10, 20, and 30 kGy, respectively, 14 pesticide samples showed high removal rates (>50%) at absorbed doses of more than 10 kGy. With the exception of procymidone, they were all completely removed at a 30 kGy irradiation dose. These results provide fundamental data on the reactivity between gamma-irradiation and pesticides in an aqueous solution. Further, an evaluation of the toxicity of radiolytic intermediate products is required.

Modernization of KGMP

  • Paik, Woo-Hyun
    • Proceedings of the PSK Conference
    • /
    • 2003.10a
    • /
    • pp.26-26
    • /
    • 2003
  • KGMP is the one of the most important part in Drug administration system which drug industry must comply to. KGMP was revised newly with the harmonization of other countries and keep face with new technologies. The big revision point is bulk drug GMP, blood products GMP, validation guideline and standardization of injection manufacturing. (omitted)

  • PDF

Antibacterial Activity of Zabofloxacin, a Novel Fluoroquinolone, against Gram-Positive Bacteria (그람양성세균에 대한 새로운 퀴놀론계 항균제 Zabofloxacin의 항균력)

  • Park, Hee-Soo;Jung, Sung-Ji;Jeong, Ji-Woong;Choi, Dong-Rack;Kim, Hyo-Hyun;Choi, Eung-Chil;Kwak, Jin-Hwan
    • YAKHAK HOEJI
    • /
    • v.55 no.1
    • /
    • pp.11-15
    • /
    • 2011
  • Zabofloxacin is a novel broad spectrum fluoroquinolone with excellent anti-pneumococcal activity. We investigated the in vitro activity of zabofloxacin against clinical isolates of gram-positive bacteria and the in vivo activity against systemic infection in mice. Zabofloxacin was very active against gram-positive bacteria except QRSA (Quinolone-resistant S. aureus) and VRE(Vancomycin-resistant Enterococci). Especially, zabofloxacin was extremely potent against clinical isolates of Streptococci. Zabofloxacin was as active as gemifloxacin against systemic infection in mice. In view of its improved antibacterial activities against gram-positive bacteria and good pharmacokinetic profiles in animals, the clinical usefulness of zabofloxacin should be established by further studies.

The Quality Regulation of Drug Excipients (의약품첨가물과 규격관리)

  • Choi, Myoeng-Sin;Hong, Chong-Hui;Jang, Seung-Jae;Kang, Chan-Soon
    • Journal of Pharmaceutical Investigation
    • /
    • v.33 no.1
    • /
    • pp.67-71
    • /
    • 2003
  • Drug excipients are material used in the formulation of pharmacologically active drugs. They have a variety of roles including dilutents/fillers/bulking agents, binders/adhesives, propellant, disintegrants, lubricants/dlidants, colors, flavors, coating agents, polising agents, fragrance, sweeteening agent, polymers and waxes. Excipient should be inert or inactive and does not interfere with the test. Nowadays within industry there has been a recent surge of interest in novel excipient for novel dosage forms. The purpose of the review is to introduce the administration systems of drug excipient about kinds, matters to be attended to change of excipients.

Modern meaning of developing a new medicine in oriental medicine and system of intellectual property (창방의 현대적 의미와 신약, 그리고 지적재산권제도)

  • Choi Hwan-Soo;Kim Yun-Kyung
    • Herbal Formula Science
    • /
    • v.12 no.1
    • /
    • pp.93-104
    • /
    • 2004
  • Recently, more and more natural herbal products are investigated and used popularly. Pharmaceutical companies of Korea are very interested in developing herbal new drugs. And oriental doctors also need popular, modernized form of oriental drugs. The objective of this article is, first, to examine current situations of drug development in Korea, second, to know general concepts of patent and third, to think about new drug development and patent in oriental medicine's point of view. With consideration of oriental medicine's characteristics, concepts of new drug and patent should be improved. Therefore, the oriental pharmaceutical industry and developments of oriental new drugs could be inspired to further efforts.

  • PDF